Printer Friendly

COMPANY INFORMATION
IntelliPharmaCeutics International Inc. 30 Worcester Rd Toronto, ON M9W 5X2 Tel: (416) 798-3001 Fax: (416) 798-3007 Contact Name Isa Odidi Industry Pharmaceuticals		Key Executives Isa Odidi, CEO Amina Odidi, CFO Develops new and generic controlled release pharmaceutical products.
FP ADVISOR COVERAGE IntelliPharmaCeutics International Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/I Nasdaq/IPCI $1.80 $6.10 $1.50 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 2,401 n.a. n.a. n.a. n.a. n.a. n.a. $19,633
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08A 12m Dec. 31/07A US$000s US$000s Operating revenue 1,278 2,297 Net income (3,765) (1,291) Total assets 3,026 6,878 US$ US$ Earnings per share* (0.22) (0.08)   * Common A Reported in accordance with U.S. GAAP

COMPANY NEWS

Results for 'IntelliPharmaCeutics International Inc.' from past 30 days: No hits. (Links are to articles.)